Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Phase Genomics
company
About
Phase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.50M
- Industries
- Bioinformatics,Biotechnology,Genetics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Phase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes and metagenomes available from any technology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$5.40M
Phase Genomics has raised a total of
$5.40M
in funding over 2 rounds. Their latest funding was raised on
Sep 29, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 29, 2020 | Grant | $3.90M | 1 |
National Institutes of Health
|
— | Detail |
| Jun 27, 2018 | Grant | $1.50M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Phase Genomics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
